This week in Other Barks & Bites: CAFC grants mandamus to Apple regarding Western District of Texas transfer from Austin to Waco; the Department of Justice’s Jeffrey Wilder remarks at an SEP conference that antitrust is “not the right tool” for licensees dissatisfied with SEP royalty rates; the Ninth Circuit reverses a class certification in a class antitrust action against Qualcomm’s SEP licensing practices because of an improper choice of law analysis; the Second Circuit affirms that Victor Miller was an independent contractor when writing the screenplay for Friday the 13th; the Federal Circuit clarifies its willfulness standard in reinstating a damages award against Cisco, and orders the USPTO to dismiss a petition for ex parte reexamination filed by a serial petitioner of IPRs at the PTAB; Judge Albright dismisses Google and YouTube’s arguments that VideoShare patent claims should be invalidated due to a terminal disclaimer linking the patent-in-suit to two previously invalidated patents; the Unified Patent Court is set to begin hearing EU patent cases by mid-2022 after Germany ratifies jurisdictional protocols; and Merck enters into a $11.5 billion agreement to buy Acceleron Pharma in a bid to stave off the 2028 patent cliff for Keytruda.
Patent
- Enablement
- Fee Shifting
- Litigation
- Other Barks & Bites for Friday, March 31: Japan Restricts Chip-Making Exports, Ocado Scores UK High Court Win in Robotic Warehousing Case, and Judge Rejects Fair Use Defense for Internet Archive
- U.S. Government Sides with Teva in Skinny Label SCOTUS Fight
- Industry, NGOs Spar Over Need to Extend TRIPS COVID IP Waiver at ITC Hearing
- Software-Related U.S. Patent Grants in 2022 Remained Steady While Chinese Software Patents Rose 8%
- The Truth Leaks Out: Justices Struggle with the Science, Sanofi Welcomes End to Functional Genus Claims in Amgen Oral Arguments
Recent Posts
- Other Barks & Bites for Friday, March 31: Japan Restricts Chip-Making Exports, Ocado Scores UK High Court Win in Robotic Warehousing Case, and Judge Rejects Fair Use Defense for Internet Archive
- U.S. Government Sides with Teva in Skinny Label SCOTUS Fight
- Industry, NGOs Spar Over Need to Extend TRIPS COVID IP Waiver at ITC Hearing
- Software-Related U.S. Patent Grants in 2022 Remained Steady While Chinese Software Patents Rose 8%
- The Truth Leaks Out: Justices Struggle with the Science, Sanofi Welcomes End to Functional Genus Claims in Amgen Oral Arguments